QUBT boosts liquidity above $1.5 billion, giving it the stability to advance quantum development and scale its photonics foundry.
Equity-backed commitment dramatically de-risks pivotal program, boosts licensing appeal, and strengthens commercialization readiness.HUNTINGTON, N.Y., ...
Solid-state battery developer QuantumScape is entering a new phase of its commercialization strategy through two simultaneous announcements: a planned stock ...
The 20th installment of Trade & Channel Strategies carried on with a focus on boosting access to medication.
Customer Initiates Product Testing with Glass Furnace Receiving First Batch of 5E Boric Acid; Results Expected Before Year-end HESPERIA, CA / ACCESS Newswire / December 9, 2025 / 5E Advanced Materials ...
Having said that, Roth centered this morning’s keynote on “Navigating Disruption in the Pharmaceutical Channels,” a ...
EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or the “Company”) today announced a series of ...
Marketplace hype means nothing until someone cracks the messy “last-mile” billing chaos that’s quietly holding back global ...
Many PBMs are also finding their business at risk as pharma–PBM tension continues to intensify. We predict that this tension will continue in 2026, especially for companies with late-stage assets in ...
Swordfish Energy Inc. announces a call to investors to bring clean hydrokinetic power to indigenous and off-grid communities ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as ...
In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery. Publishing in Trends in Pharmacological Sciences, their recommendations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results